Quoin Pharmaceuticals Ltd. (QNRX) Operating cash flow 2019–2025
Quoin Pharmaceuticals Ltd. (QNRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$13.5MFY2025 · since FY2019: -$1.3M → -$13.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.5M | -72.3% |
| FY2024 | -$7.9M | +0.1% |
| FY2023 | -$7.9M | +7.3% |
| FY2022 | -$8.5M | -48.3% |
| FY2021 | -$5.7M | -327.3% |
| FY2020 | -$1.3M | -3.1% |
| FY2019 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More QNRX financial trends
QNRX RevenueQNRX Net incomeQNRX Net marginQNRX Gross profitQNRX Gross marginQNRX Operating incomeQNRX Operating marginQNRX Free cash flowQNRX Capital expendituresQNRX Return on equityQNRX Stock buybacksQNRX Dividends paidQNRX Total assetsQNRX Total liabilitiesQNRX Shareholders’ equityQNRX overview →